ArticleFrontiers in psychiatry2025

A randomized, sham-controlled clinical trial to evaluate the NET Device™ for reducing withdrawal symptom severity during opioid discontinuation.

Mark K Greenwald et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.